Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: A natural bioflavonoid

Pharmaceutical Research

Volumn 26, Issue 5, 2009, Pages 1217-1225

  Majumdar, Soumyajit ^a,b   Srirangam, Ramesh ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Hesperetin; Hesperidin; Ocular; Permeability; Solubility

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; HESPERIDIN;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CORNEA; DIFFUSION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; MALE; NONHUMAN; PH; PHYSICAL CHEMISTRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RABBIT; SCLERA;

ANIMALS; BETA-CYCLODEXTRINS; CORNEA; DRUG STABILITY; EYE DISEASES; HESPERIDIN; HYDROGEN-ION CONCENTRATION; MALE; OPHTHALMIC SOLUTIONS; PERMEABILITY; RABBITS; RETINAL PIGMENT EPITHELIUM; SCLERA; SOLUBILITY;

EID: 63949087793     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9729-6     Document Type: Article

References (37)

1. A. Ryskulova K. Turczyn D. M. Makuc M. F. Cotch R. J. Klein R. Janiszewski 2008 Self-reported age-related eye diseases and visual impairment in the United States: results of the 2002 national health interview survey Am. J. Public Health 98 454 461
2. J. L. Wilkinson-Berka 2004 Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide Curr. Pharm. Des. 10 3331 3348
3. X. R. Chiou GC 2004 Effects of some natural flavonoids on retinal function recovery after ischemic insult in the rat J. Ocular. Pharmacol. Therap. 20 107 113
4. A. Garg S. Garg L. J. Zaneveld A. K. Singla 2001 Chemistry and pharmacology of the citrus bioflavonoid hesperidin Phytother. Res. 15 655 669
5. J. M. Beiler G. J. Martin 1948 Inhibition of hyaluronidase action by derivatives of hesperidin J. Biol. Chem. 174 31 34
6. J. Zhang R. A. Stanley L. D. Melton M. A. Skinner 2007 Inhibition of lipid oxidation by phenolic antioxidants in relation to their physicochemical properties Pharmacologyonline 1 180 189
7. A. Hirata Y. Murakami M. Shoji Y. Kadoma S. Fujisawa 2005 Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression Anticancer Res. 25 3367 3374
8. S. P. Ayalasomayajula A. C. Amrite U. B. Kompella 2004 Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas Eur. J. Pharmacol. 498 275 278
9. E. M. Galati M. T. Monforte S. Kirjavainen A. M. Forestieri A. Trovato M. M. Tripodo 1994 Biological effects of hesperidin, a citrus flavonoid. (Note I): antiinflammatory and analgesic activity Farmaco 40 709 712
10. M. T. Monforte A. Trovato S. Kirjavainen A. M. Forestieri E. M. Galati R. B. Lo Curto 1995 Biological effects of hesperidin, a citrus flavonoid. (note II): hypolipidemic activity on experimental hypercholesterolemia in rat Farmaco 50 595 599
11. E. M. Galati A. Trovato S. Kirjavainen A. M. Forestieri A. Rossitto M. T. Monforte 1996 Biological effects of hesperidin, a citrus flavonoid. (Note III): antihypertensive and diuretic activity in rat Farmaco 51 219 221
12. T. Tanaka H. Makita M. Ohnishi H. Mori K. Satoh A. Hara T. Sumida K. Fukutani T. Tanaka H. Ogawa 1997 Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination Cancer Res. 57 246 252
13. T. Tanaka H. Makita K. Kawabata H. Mori M. Kakumoto K. Satoh A. Hara T. Sumida T. Tanaka H. Ogawa 1997 Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin Carcinogenesis 18 957 965
14. B. Ameer R. A. Weintraub J. V. Johnson R. A. Yost R. L. Rouseff 1996 Flavanone absorption after naringin, hesperidin, and citrus administration Clin. Pharmacol. Ther. 60 34 40
15. A. Gil-Izquierdo M. I. Gil F. A. Tomas-Barberan F. Ferreres 2003 Influence of industrial processing on orange juice flavanone solubility and transformation to chalcones under gastrointestinal conditions J. Agric. Food Chem. 51 3024 3028
16. T. H. Tsai M. C. Liu 2004 Determination of extracellular hesperidin in blood and bile of anaesthetized rats by microdialysis with high-performance liquid chromatography: a pharmacokinetic application J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 806 161 166
17. Y. Mitsunaga H. Takanaga H. Matsuo M. Naito T. Tsuruo H. Ohtani Y. Sawada 2000 Effect of bioflavonoids on vincristine transport across blood-brain barrier Eur. J. Pharmacol. 395 193 201
18. M. Ofer S. Wolffram A. Koggel H. Spahn-Langguth P. Langguth 2005 Modulation of drug transport by selected flavonoids: involvement of P-gp and OCT? Eur. J. Pharm. Sci. 25 263 271
19. V. M. Breinholt E. A. Offord C. Brouwer S. E. Nielsen K. Brosen T. Friedberg 2002 In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids Food Chem. Toxicol. 40 609 616
20. S. Kobayashi S. Tanabe M. Sugiyama Y. Konishi 2008 Transepithelial transport of hesperetin and hesperidin in intestinal Caco-2 cell monolayers Biochim. Biophys. Acta 1778 33 41
21. H. Serra, T. Mendes, M. R. Bronze, and A. L. Simplicio. Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones. Bioorg. Med. Chem. 16:4009-4018 (2008).
22. C. Manach C. Morand A. Gil-Izquierdo C. Bouteloup-Demange C. Remesy 2003 Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice Eur. J. Clin. Nutr. 57 235 242
23. A. K. Mitra, S. Macha, and P. M. Hughes. Ophthalmic Drug Delivery Systems. Marcel Dekker, New York, 2003.
24. M. M. Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 248 254
25. N. M. Holekamp M. A. Thomas A. Pearson 2005 The safety profile of long-term, high-dose intraocular corticosteroid delivery Am. J. Ophthalmol. 139 421 428
26. T. Jansen B. Xhonneux J. Mesens M. Borgers 1990 Beta-cyclodextrins as vehicles in eye-drop formulations: an evaluation of their effects on rabbit corneal epithelium Lens Eye Toxic. Res. 7 459 468
27. P. Saarinen-Savolainen T. Jarvinen K. Araki-Sasaki H. Watanabe A. Urtti 1998 Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line Pharm. Res. 15 1275 1280
28. T. Loftssona T. Jarvinen 1999 Cyclodextrins in ophthalmic drug delivery Adv. Drug Deliv. Rev. 36 59 79
29. S. Tommasini M. L. Calabro R. Stancanelli P. Donato C. Costa S. Catania V. Villari P. Ficarra R. Ficarra 2005 The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin J. Pharm. Biomed. Anal. 39 572 580
30. D. K. Wilcox 1987 Extracellular release of acid hydrolases from cultured retinal pigmented epithelium Invest. Ophthalmol. Vis. Sci. 28 76 82
31. A. J. Adler 1989 Selective presence of acid hydrolases in the interphotoreceptor matrix Exp. Eye Res. 49 1067 1077
32. E. Mannermaa K. S. Vellonen A. Urtti 2006 Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics Adv. Drug Deliv. Rev. 58 1136 1163
33. W. S. Marshall S. D. Klyce 1983 Cellular and paracellular pathway resistances in the "tight" Cl- -secreting epithelium of rabbit cornea J. Membr. Biol. 73 275 282
34. M. R. Prausnitz J. S. Noonan 1998 Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye J. Pharm. Sci. 87 1479 1488
35. V. Kansara Y. Hao A. K. Mitra 2007 Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina J. Ocul. Pharmacol. Ther. 23 321 334
36. S. Majumdar K. Hippalgaonkar M. A. Repka 2008 Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea Int. J. Pharm. 348 175 178
37. S. Majumdar Y. E. Nashed K. Patel R. Jain M. Itahashi D. M. Neumann J. M. Hill A. K. Mitra 2005 Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations J. Ocul. Pharmacol. Ther. 21 463 474